Mineralys Therapeutics (MLYS) Short Interest
Nasdaq • MLYS • US6031701013
As of Oct 22, 2026, ORTEX estimated 11.6% of free float sold short, 5.7 days to cover, cost to borrow 0.5%. Sign up for live short interest data.
Nasdaq • MLYS • US6031701013
As of Oct 22, 2026, ORTEX estimated 11.6% of free float sold short, 5.7 days to cover, cost to borrow 0.5%. Sign up for live short interest data.
This page tracks how heavily Mineralys Therapeutics (Nasdaq:MLYS) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Mineralys Therapeutics (Nasdaq: MLYS) has a market capitalization of $1.36B. Last close $15.33 (as of 2026-11-09); 52-week range $14.91 to $47.65. ORTEX data as of 2026-10-22: short interest was 11.57% of free float, 5.7 days to cover and the average cost to borrow was 0.5%. Sign up for live short interest data.